UK Prime Minister Andy Burnham, who lost his father to Alzheimer's disease last week, has been urged to implement a "cancer-style" reform of dementia care pathways. A new proposal ...

Earlier this year, the FDA released draft guidance endorsing Bayesian methods and simulation-based evidence in clinical trials in a significant shift in how regulators think about predictive medicine.

An adjuvanted, trivalent influenza vaccine developed by CSL Seqirus and recently approved in the UK, Aujemflu, will be deployed ahead of the 2027/28 flu season under an agreement with the government.

Iambic Therapeutics, which specialises in applying AI to drug discovery and development, has filed for an IPO on the Nasdaq, shortly after adding AbbVie to its roster of pharma pa ...

A consumer advocacy group has scrutinised some of the Most Favoured Nation (MFN) pricing deals the Trump administration has announced with 27 pharma companies and concludes that claims about the ...

Adding ITM will also give Telix a pipeline of follow-up radiopharma candidates, including clinical-stage diagnostics and ...

The recommendation by the CHMP sets up an EU approval in the coming weeks for Klygefa (gefurulimab), a dual-binding nanobody ...

Beacon Therapeutics is preparing to file for approval of its gene therapy for eye disorder X-linked retinitis pigmentosa (XLRP) after reporting positive results in a pivotal trial. In the phase 2/3 ...

Avalere Health was the most successful agency, winning three Golds, a Silver and the highly contested accolade of PMi Agency ...

ADARx Pharmaceuticals, a San Diego-based biotech developing siRNA therapies for various diseases, has announced the terms for its IPO, hoping to raise up to $372 million from the sale of 21.9 million ...

The Danish Group stated that the new corporate culture – dubbed 'The Novo Way' – centres around four Cs; namely, customer ...

Around 1,000 patients in England with a form of incurable breast cancer will be able to get access to AstraZeneca and Daiichi ...